Michael Gent

53.8k citations
230 papers · 34.9k indexed · 22 hit papers · h-index 90

Michael Gent

227 papers receiving 32.3k citations

Hit Papers

Rivaroxaban versus enoxapar...741197420261991200850010001.5k2.0k

Peers

Michael Gent
Comparison fields: 5 of 180
  • Internal Medicine 16.1k
  • Cardiology and Cardiovascular Medicine 20.2k
  • Hematology 5.1k
  • Emergency Medical Services 2.6k
  • Surgery 9.1k
Replace Martin H. Prins with:
Martin H. Prins Netherlands
Sam Schulman Canada
Jack Hirsh Canada
Mark Crowther Canada
John W. Eikelboom Canada
John A. Heit United States
Samuel Z. Goldhaber United States
Frits R. Rosendaal Netherlands
Harry R. Büller Netherlands
Susan R. Kahn Canada
Michael Gent relative to Martin H. Prins Netherlands Martin H. Prins's profile →
Citations per field
00.5×1.5×
Martin H. Prins · 1×
Citations per year

Countries citing papers authored by Michael Gent

Since Specialization
Citations

This map shows the geographic impact of Michael Gent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gent more than expected).

Fields of papers citing papers by Michael Gent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gent. The network helps show where Michael Gent may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Gent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Gent Line = papers co-authored together Michael Gent links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2009230
2 20093
3
Abstract 1157: A Multicentre Randomized Trial Comparing Heparin/warfarin Versus Aspirin As Primary Thromboprophylaxis For Two Years After Fontan Procedure In Children
20081
4 200756
5 200747
6
An Evaluation of D-Dimer in the Diagnosis of Pulmonary Embolism
20067
7
Fondaparinux ou enoxaparin pour le traitement initial de la thrombose veineuse profonde symptomatique. Un essai randomisé
20052
8 200581
9 200366
10
A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE).
200213
11
The Relationships Among Dose, Effectiveness, and Side Effects
199817
12 19978
13 199683
14
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparinbreakdown →
19951700
15
Canadian atrial fibrillation anticoaguiation (CAFA) studybreakdown →
1991831
16 199126
17 1990182
18 19792
19
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
19759
20 197039

About Michael Gent

Michael Gent is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology, having authored 230 papers that have together received 34.9k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (105 papers), Atrial Fibrillation Management and Outcomes (59 papers), Antiplatelet Therapy and Cardiovascular Diseases (40 papers), Cardiac Arrhythmias and Treatments (26 papers), Cardiac pacing and defibrillation studies (25 papers), Acute Myocardial Infarction Research (24 papers), Blood Coagulation and Thrombosis Mechanisms (22 papers) and Acute Ischemic Stroke Management (22 papers). The work is most often cited by research in Internal Medicine (16.1k citations), Cardiology and Cardiovascular Medicine (20.2k citations) and Hematology (5.1k citations). Michael Gent has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Jack Hirsh, Stuart J. Connolly, Robin S. Roberts, Mark N. Levine, John A. Cairns, J. Hirsh, Jim A. Julian, David L. Sackett, Howard A. Rowley and Randall T. Higashida. Their work appears in journals such as New England Journal of Medicine, Circulation, Thrombosis and Haemostasis, Thrombosis Research and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026